We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLYM
3751
Climb Bio
CLYM
$795M
$17.5K ﹤0.01%
14,102
+5,972
+73% +$7.43K
ALVO icon
3752
Alvotech
ALVO
$1.29B
$17.4K ﹤0.01%
1,913
-6,414
-77% -$60.2K
PAY icon
3753
Paymentus
PAY
$5.11B
$17.4K ﹤0.01%
532
-8,206
-94% -$275K
FF icon
3754
Future Fuel
FF
$279M
$17.3K ﹤0.01%
4,455
+1,936
+77% +$7.79K
CHRS icon
3755
Coherus Oncology
CHRS
$187M
$17.2K ﹤0.01%
23,554
+13,166
+127% +$11.4K
LESL icon
3756
Leslie's
LESL
$12.4M
$17.2K ﹤0.01%
2,048
+611
+43% +$8.04K
AARD
3757
Aardvark Therapeutics
AARD
$157M
$17.1K ﹤0.01%
+1,268
New +$13.1K
DTI icon
3758
Drilling Tools International
DTI
$86.4M
$17.1K ﹤0.01%
6,003
+985
+20% +$2.45K
FRHC icon
3759
Freedom Holding
FRHC
$9.61B
$17.1K ﹤0.01%
+117
New +$17.3K
ONDS icon
3760
Ondas Inc
ONDS
$5.55B
$17.1K ﹤0.01%
+8,893
New +$9.93K
PARAA
3761
DELISTED
Paramount Global Class A
PARAA
$17.1K ﹤0.01%
744
-325
-30% -$7.35K
GDS icon
3762
GDS Holdings
GDS
$6.54B
$17.1K ﹤0.01%
558
+334
+149% +$8.47K
GPRO icon
3763
GoPro
GPRO
$107M
$17.1K ﹤0.01%
22,517
+6,997
+45% +$4.55K
NMRA icon
3764
Neumora Therapeutics
NMRA
$315M
$17K ﹤0.01%
23,227
+3,316
+17% +$2.51K
OVID icon
3765
Ovid Therapeutics
OVID
$482M
$17K ﹤0.01%
51,520
+27,674
+116% +$8.34K
EWM icon
3766
iShares MSCI Malaysia ETF
EWM
$331M
$17K ﹤0.01%
698
+679
+3,574% +$16.2K
RHLD
3767
Resolute Holdings Management
RHLD
$1.09B
$17K ﹤0.01%
533
+155
+41% +$4.75K
KSPI icon
3768
Kaspi.kz JSC
KSPI
$18.1B
$17K ﹤0.01%
200
-725
-78% -$61.8K
USRT icon
3769
iShares Core US REIT ETF
USRT
$4.53B
$17K ﹤0.01%
+300
New +$16.8K
CRVS icon
3770
Corvus Pharmaceuticals
CRVS
$1.24B
$16.9K ﹤0.01%
4,226
+1,227
+41% +$4.46K
LRMR icon
3771
Larimar Therapeutics
LRMR
$448M
$16.9K ﹤0.01%
5,839
+1,038
+22% +$2.4K
CLAR icon
3772
Clarus
CLAR
$146M
$16.8K ﹤0.01%
4,854
+79
+2% +$268
TIXT
3773
DELISTED
TELUS International
TIXT
$16.8K ﹤0.01%
4,619
+2,185
+90% +$6.21K
SCZ icon
3774
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$16.7K ﹤0.01%
230
-6,554
-97% -$444K
VRA icon
3775
Vera Bradley
VRA
$95M
$16.7K ﹤0.01%
7,552
+313
+4% +$646
149 150
151
152 153

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.